This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

AI models are using material from retracted scientific papers

The news: Some AI chatbots rely on flawed research from retracted scientific papers to answer questions, according to recent studies. In one such study, researchers asked OpenAI’s ChatGPT questions based on information from 21 retracted papers on medical imaging. The chatbot’s answers referenced retracted papers in five cases but advised caution in only three. 

The bigger picture: The findings raise serious questions about how reliable AI tools are at evaluating scientific research, or answering people’s health queries. They could also complicate efforts to invest in AI tools for scientists. And it’s not an easy problem to fix. Read the full story.

—Ananya

Join us at 1pm ET today to meet our Innovator of the Year

Every year, MIT Technology Review awards Innovator of the Year to someone whose work we admire. This year we selected Sneha Goenka, who designed the computations behind the world’s fastest whole-genome sequencing method.

Her work could transform medical care by allowing physicians to sequence a patient’s genome and diagnose genetic conditions in less than eight hours.

Register here to join an exclusive subscriber-only Roundtable conversation with Goenka, Leilani Battle, assistant professor at the University of Washington, and our editor in chief Mat Honan at 1pm ET today. 

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 There’s scant evidence tylenol use during pregnancy causes autism
The biggest cause of autism is genetic—that’s why it often runs in families. (Scientific American $)
+ Anti-vaxxers are furious the White House didn’t link autism to vaccines. (Ars Technica)
+ The company that sells Tylenol is being forced to defend the medicine’s safety. (Axios)

2 Nvidia is investing up to $100 billion in OpenAI
OpenAI is already a major customer, but this will bind the two even more closely together. (Reuters $)
+ America’s top companies keep talking about AI—but they can’t explain its upsides. (FT $)

3 Denmark’s biggest airport was shut down by drones
Its prime minister refused to rule out Russian involvement. (FT $)
+ Poland and Estonia have been speaking up at the UN about Russian incursions into their airspace. (The Guardian)

4 Google is facing another antitrust trial in the US
This one will focus on remedies to its dominance of the advertising tech market. (Ars Technica)
+ The FTC is also taking Amazon to court over accusations the company tricks people into paying for Prime. (NPR)
+ The Supreme Court has ruled to allow Trump’s firing of a Democrat FTC commissioner. (NYT $)

5 Here’s the potential impact of Trump’s H-1B crackdown on tech
It’s likely to push a lot of skilled workers elsewhere. (Rest of World)

6 How TikTok’s deal to stay in the US will work
Oracle will manage its algorithm for US users and oversee security operations. (ABC)
+ It’s a giant prize for Trump’s friend Larry Ellison, Oracle’s cofounder. (NYT $)
+ Trump and his allies are now likely to exert a lot of political influence over TikTok. (WP $)

7 Record labels are escalating their lawsuit against an AI music startup
They claim it knowingly pirated songs from YouTube to train its generative AI models. (The Verge $)
+ AI is coming for music, too. (MIT Technology Review

8 There’s a big fight in the US over who pays for weight loss drugs
Although they’ll save insurers money long-term, they cost a lot upfront. (WP $)
+ We’re learning more about what weight-loss drugs do to the body. (MIT Technology Review)

9 How a lone vigilante ended up blowing up 5G towers
A little bit of knowledge can be a dangerous thing. (Wired $)

10 The moon is rusting 🌕
And it’s our fault. Awkward! (Nature)

Quote of the day

“At the heart of this is people trying to look for simple answers to complex problems.”

—James Cusack, chief executive of an autism charity called Autistica, tells Nature what he thinks is driving Trump and others to incorrectly link the condition with Tylenol use during pregnancy. 

One more thing

A mobility walker sinking in an hourglass.
SARAH ROGERS / MITTR | PHOTOS GETTY

Maybe you will be able to live past 122

How long can humans live? This is a good time to ask the question. The longevity scene is having a moment, and a few key areas of research suggest that we might be able to push human life spans further, and potentially reverse at least some signs of aging.

Researchers can’t even agree on what the exact mechanisms of aging are and which they should be targeting. Debates continue to rage over how long it’s possible for humans to live—and whether there is a limit at all.

But it looks likely that something will be developed in the coming decades that will help us live longer, in better health. Read the full story.

—Jessica Hamzelou

We can still have nice things

A place for comfort, fun and distraction to brighten up your day. (Got any ideas? Drop me a line or skeet ’em at me.)

+ This website lets you send a letter to your future self. 
+ Here’s what Brian Eno has to say about art.
+ This photographer takes stunning pictures of Greenland. 
+ The Hungarian dish Rakott krumpli isn’t going to win any health plaudits, but it looks very comforting all the same.

Read more

Some AI chatbots rely on flawed research from retracted scientific papers to answer questions, according to recent studies. The findings, confirmed by MIT Technology Review, raise questions about how reliable AI tools are at evaluating scientific research and could complicate efforts by countries and industries seeking to invest in AI tools for scientists.

AI search tools and chatbots are already known to fabricate links and references. But answers based on the material from actual papers can mislead as well if those papers have been retracted. The chatbot is “using a real paper, real material, to tell you something,” says Weikuan Gu, a medical researcher at the University of Tennessee in Memphis and an author of one of the recent studies. But, he says, if people only look at the content of the answer and do not click through to the paper and see that it’s been retracted, that’s really a problem. 

Gu and his team asked OpenAI’s ChatGPT, running on the GPT-4o model, questions based on information from 21 retracted papers about medical imaging. The chatbot’s answers referenced retracted papers in five cases but advised caution in only three. While it cited non-retracted papers for other questions, the authors note that it may not have recognized the retraction status of the articles. In a study from August, a different group of researchers used ChatGPT-4o mini to evaluate the quality of 217 retracted and low-quality papers from different scientific fields; they found that none of the chatbot’s responses mentioned retractions or other concerns. (No similar studies have been released on GPT-5, which came out in August.)

The public uses AI chatbots to ask for medical advice and diagnose health conditions. Students and scientists increasingly use science-focused AI tools to review existing scientific literature and summarize papers. That kind of usage is likely to increase. The US National Science Foundation, for instance, invested $75 million in building AI models for science research this August.

“If [a tool is] facing the general public, then using retraction as a kind of quality indicator is very important,” says Yuanxi Fu, an information science researcher at the University of Illinois Urbana-Champaign. There’s “kind of an agreement that retracted papers have been struck off the record of science,” she says, “and the people who are outside of science—they should be warned that these are retracted papers.” OpenAI did not provide a response to a request for comment about the paper results.

The problem is not limited to ChatGPT. In June, MIT Technology Review tested AI tools specifically advertised for research work, such as Elicit, Ai2 ScholarQA (now part of the Allen Institute for Artificial Intelligence’s Asta tool), Perplexity, and Consensus, using questions based on the 21 retracted papers in Gu’s study. Elicit referenced five of the retracted papers in its answers, while Ai2 ScholarQA referenced 17, Perplexity 11, and Consensus 18—all without noting the retractions.

Some companies have since made moves to correct the issue. “Until recently, we didn’t have great retraction data in our search engine,” says Christian Salem, cofounder of Consensus. His company has now started using retraction data from a combination of sources, including publishers and data aggregators, independent web crawling, and Retraction Watch, which manually curates and maintains a database of retractions. In a test of the same papers in August, Consensus cited only five retracted papers. 

Elicit told MIT Technology Review that it removes retracted papers flagged by the scholarly research catalogue OpenAlex from its database and is “still working on aggregating sources of retractions.” Ai2 told us that its tool does not automatically detect or remove retracted papers currently. Perplexity said that it “[does] not ever claim to be 100% accurate.” 

However, relying on retraction databases may not be enough. Ivan Oransky, the cofounder of Retraction Watch, is careful not to describe it as a comprehensive database, saying that creating one would require more resources than anyone has: “The reason it’s resource intensive is because someone has to do it all by hand if you want it to be accurate.”

Further complicating the matter is that publishers don’t share a uniform approach to retraction notices. “Where things are retracted, they can be marked as such in very different ways,” says Caitlin Bakker from University of Regina, Canada, an expert in research and discovery tools. “Correction,” “expression of concern,” “erratum,” and “retracted” are among some labels publishers may add to research papers—and these labels can be added for many reasons, including concerns about the content, methodology, and data or the presence of conflicts of interest. 

Some researchers distribute their papers on preprint servers, paper repositories, and other websites, causing copies to be scattered around the web. Moreover, the data used to train AI models may not be up to date. If a paper is retracted after the model’s training cutoff date, its responses might not instantaneously reflect what’s going on, says Fu. Most academic search engines don’t do a real-time check against retraction data, so you are at the mercy of how accurate their corpus is, says Aaron Tay, a librarian at Singapore Management University.

Oransky and other experts advocate making more context available for models to use when creating a response. This could mean publishing information that already exists, like peer reviews commissioned by journals and critiques from the review site PubPeer, alongside the published paper.  

Many publishers, such as Nature and the BMJ, publish retraction notices as separate articles linked to the paper, outside paywalls. Fu says companies need to effectively make use of such information, as well as any news articles in a model’s training data that mention a paper’s retraction. 

The users and creators of AI tools need to do their due diligence. “We are at the very, very early stages, and essentially you have to be skeptical,” says Tay.

Ananya is a freelance science and technology journalist based in Bengaluru, India.

Read more

Entrepreneurial AI Pitfalls: Stop Making These 3 AI Mistakes by Social Media Examiner

Are you struggling to introduce AI into your business while keeping your team engaged and productive? Wondering how to navigate the complexities of technological change without creating chaos in your organization? In this article, you’ll discover how to strategically implement AI across your business operations while maintaining team morale and building a stronger, more capable […]

The post Entrepreneurial AI Pitfalls: Stop Making These 3 AI Mistakes appeared first on Social Media Examiner.

Read more
1 365 366 367 368 369 3,215